Secure Drug Supply Chain Act of 2026 aims to prevent unlawful drug imports from China and other adversarial countries.

The Secure Drug Supply Chain Act of 2026 seeks to enhance the safety and security of the U.S. pharmaceutical supply chain by preventing the importation of counterfeit, unapproved, misbranded, or adulterated drugs from adversarial countries. The Act mandates the Food and Drug Administration to enforce stricter regulations on drug imports, particularly from China and other countries known for intellectual property theft, forced labor, and counterfeit drug distribution.

Secure Drug Supply Chain Act of 2026 aims to prevent unlawful drug imports from China and other adversarial countries.

The Secure Drug Supply Chain Act of 2026 seeks to enhance the safety and security of the U.S. pharmaceutical supply chain by preventing the importation of counterfeit, unapproved, misbranded, or adulterated drugs from adversarial countries. The Act mandates the Food and Drug Administration to enforce stricter regulations on drug imports, particularly from China and other countries known for intellectual property theft, forced labor, and counterfeit drug distribution.